Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 17805
Country/Region: South Sudan
Year: 2016
Main Partner: RTI International
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USDOD
Total Funding: $1,188,200 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $24,472
Testing: HIV Testing and Counseling (HVCT) $673,823
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $27,594
Treatment: Adult Treatment (HTXS) $462,311
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 147
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 98
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 5,929
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 49,674
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 55,848
HTS_TST Service Delivery Point (Community): Mobile testing 2017 37,937
HTS_TST Service Delivery Point (Facility): Outpatient 2017 4,198
HTS_TST Service Delivery Point (Facility): PMTCT 2017 2,040
HTS_TST Service Delivery Point (Facility): VCT 2017 11,673
HTS_TST Sum of Aggregated Age/Sex <15 2017 245
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 55,603
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 55,848
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 37
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 24
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 558
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 2,993
PMTCT_ART Already on ART at beginning of current pregnancy 2017 62
PMTCT_ART New on ART 2017 20
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 2,040
PMTCT_STAT By: Known positives at entry 2017 62
PMTCT_STAT By: Number of new positives identified 2017 20
PMTCT_STAT Number of new ANC and L&D clients 2017 2,545
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 2,040
PMTCT_STAT Sum of Positives Status disaggregates 2017 82
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 22
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 6
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 50
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 80
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 80
TB_SCREENDX Screen Result: Screened Positive for TB 2017 80
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 841
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 4,267
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 5,108
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 3
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 27
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 7
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 63
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 100
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 100
TX_CURR Aggregated Age/Sex: 15+ Female 2017 934
TX_CURR Aggregated Age/Sex: 15+ Male 2017 4,741
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 5,675
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 5,675
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 5,675
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 417
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 2,729
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 3,146
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 3,146
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 320
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,934
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 2,254
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 3,146
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 417
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,729